Skip to Main Content

Try STAT+ TODAY

drug marketing

Most Read

Pharmalot Ed Silverman

Chicago will license pharma sales reps to fight opioid overprescribing

Pharmalot Ed Silverman

FDA slams drug maker for touting unapproved leukemia treatment to docs

Pharmalot Ed Silverman

FDA to hold long-awaited meeting to review off-label marketing

First Opinion Paul D. Thacker

Don’t rewrite history: ‘Sunshine’ law was meant to protect docs from undue influence

Business Rebecca Robbins

Why Democratic convention viewers saw so many drug ads

Pharmalot Ed Silverman

Former execs at J&J division convicted of illegally distributing devices

Business Rebecca Robbins

Meet the furry pitchmen promoting a new drug for dogs scared of fireworks

Business Rebecca Robbins

Comic books. Lesson plans. How drug companies target kids

All Coverage

Pharmalot Ed Silverman

FDA deal with Amarin is unlikely to spark more off-label promotion

Exclusive Rebecca Robbins

Drug makers now spend $5 billion a year on advertising. Here’s what that buys.

advertisement

Business Rebecca Robbins

Inside the $100 million ad blitz for a $1,100-a-pill drug for hepatitis C

Pharmalot Ed Silverman

Lawmaker seeks to end tax breaks for consumer drug ads

Exclusive Sheila Kaplan

Doctors promoting treatments on social media routinely fail to disclose ties to drug makers

Exclusive Sheila Kaplan

Here’s how doctors tweet medical advice — and what they’re not telling you

Business Rebecca Robbins

How much is an extra month of life worth? Drug makers face pressure to calculate

Business Megan Thielking

How drug ad narrators take the scariness out of side effects

Health Rebecca Robbins

In the shadow of an opioid crisis, Super Bowl ad spotlights chronic pain patients

Business Rebecca Robbins

NFL games are magnets for drug ads. But the Super Bowl isn’t. Here’s why

Pharmalot Ed Silverman

FDA issues all-time low number of violation letters for drug promotions